A
Allan Donner
Researcher at University of Western Ontario
Publications - 15
Citations - 2629
Allan Donner is an academic researcher from University of Western Ontario. The author has contributed to research in topics: Randomized controlled trial & Health care. The author has an hindex of 10, co-authored 15 publications receiving 2245 citations. Previous affiliations of Allan Donner include University of Ottawa.
Papers
More filters
Journal ArticleDOI
Guidelines for Reporting Reliability and Agreement Studies (GRRAS) were proposed.
Jan Kottner,Laurent Audigé,Stig Brorson,Allan Donner,Byron J. Gajewski,Asbjørn Hróbjartsson,Chris Roberts,Mohamed Shoukri,David L. Streiner +8 more
TL;DR: In this paper, the authors developed guidelines for reporting reliability and agreement studies in interrater and intra-arater reliability and agreements, and proposed 15 issues that should be addressed when reporting such studies.
Journal ArticleDOI
Guidelines for Reporting Reliability and Agreement Studies (GRRAS) were proposed.
Jan Kottner,Laurent Audigé,Stig Brorson,Allan Donner,Byron J. Gajewski,Asbjørn Hróbjartsson,Chris Roberts,Mohamed Shoukri,David L. Streiner +8 more
TL;DR: The objective was to develop guidelines for reporting reliability and agreement studies and the proposed guidelines intend to improve the quality of reporting.
Journal ArticleDOI
Methods in health service research: Evaluation of health interventions at area and organisation level
Obioha C Ukoumunne,Martin Gulliford,Susan Chinn,Jonathan A C Sterne,Peter Burney,Allan Donner +5 more
TL;DR: Evaluation of cluster level interventions may be difficult because only a small number of organisational units of large size may be available for study, evaluation may be at individual level.
Journal ArticleDOI
Randomised study of n of 1 trials versus standard practice.
TL;DR: N Of 1 trials led to less theophylline use without adverse effects on exercise capacity or quality of life in patients with irreversible chronic airflow limitation, and data directly support the presence of a clinically important bias towards unnecessary treatment during open prescription.
Journal ArticleDOI
Theophylline for Irreversible Chronic Airflow Limitation: A Randomized Study Comparing n of 1 Trials to Standard Practice
Jeffrey L. Mahon,Andreas Laupacis,Richard V. Hodder,Douglas A. McKim,Nigel A. M. Paterson,Thomas E. Wood,Allan Donner +6 more
TL;DR: Using n of 1 trials to guide theophylline therapy in patients with irreversible CAL did not improve their quality of life or exercise capacity, or reduce drug usa e, over 1 year compared to standard practice.